Wird geladen...
Sarecycline: a narrow spectrum tetracycline for the treatment of moderate-to-severe acne vulgaris
Sarecycline is a novel, narrow-spectrum, once-daily tetracycline-derived oral antibiotic that is FDA-approved in the US to be taken with or without food for moderate-to-severe acne vulgaris for ages 9 years of age and older. Sarecycline possesses anti-inflammatory properties and potent activity agai...
Gespeichert in:
| Veröffentlicht in: | Future Microbiol |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Future Medicine Ltd
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6802708/ https://ncbi.nlm.nih.gov/pubmed/31475868 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fmb-2019-0199 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|